Press Release: MorphoSys : EQS-Adhoc: Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQS-Ad-hoc: MorphoSys AG / Key word(s): Squeeze Out Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00 12-Jul-2024 / 14:34 CET/CEST Disclosure
Read full article »
MorphoSys is a Germany-based biopharmaceutical company that researches and develops oncology medicines for the treatment of cancer.
Read more